11-67487147-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_003977.4(AIP):c.241C>T(p.Arg81*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_003977.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AIP | NM_003977.4 | c.241C>T | p.Arg81* | stop_gained | 2/6 | ENST00000279146.8 | NP_003968.3 | |
AIP | NM_001302960.2 | c.241C>T | p.Arg81* | stop_gained | 2/6 | NP_001289889.1 | ||
AIP | NM_001302959.2 | c.64C>T | p.Arg22* | stop_gained | 2/6 | NP_001289888.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AIP | ENST00000279146.8 | c.241C>T | p.Arg81* | stop_gained | 2/6 | 1 | NM_003977.4 | ENSP00000279146.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461862Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727232
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 22, 2023 | This sequence change creates a premature translational stop signal (p.Arg81*) in the AIP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AIP are known to be pathogenic (PMID: 23321498, 26186299). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with AIP-related conditions (PMID: 18381572). ClinVar contains an entry for this variant (Variation ID: 41167). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 22, 2024 | The p.R81* variant (also known as c.241C>T), located in coding exon 2 of the AIP gene, results from a C to T substitution at nucleotide position 241. This changes the amino acid from an arginine to a stop codon within coding exon 2. This variant has been reported in multiple individuals diagnosed with pituitary adenomas (Leontiou CA et al. J Clin Endocrinol Metab, 2008 Jun;93:2390-401; Toledo RA et al. Clinics (Sao Paulo), 2010 Apr;65:407-15; Dutta P et al. J Clin Endocrinol Metab, 2019 Aug;104:3539-3544; Guaraldi F et al. Pituitary, 2012 Dec;15 Suppl 1:S61-7; Gaspar LM et al. J Endocrinol Invest, 2023 Nov;46:2299-2307; Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. (Leontiou CA et al. J Clin Endocrinol Metab, 2008 Jun;93:2390-401). (Toledo RA et al. Clinics (Sao Paulo), 2010 Apr;65:407-15). (Dutta P et al. J Clin Endocrinol Metab, 2019 Aug;104:3539-3544). (Guaraldi F et al. Pituitary, 2012 Dec;15 Suppl 1:S61-7). (Gaspar LM et al. J Endocrinol Invest, 2023 Nov;46:2299-2307). - |
Somatotroph adenoma Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at